About the Symposium:
This engaging, fast-paced 1.5 CNE symposium is intended for oncology nurses providing care for multiple myeloma patients. Four highly experienced nurses will use case scenarios based on real-life patients to share take-home nurse and patient tools, along with the latest research, that emphasize shared decision making, symptom management, and nursing implications in the context of rapidly evolving therapeutic regimens for newly diagnosed and relapsed myeloma.
The Satellite Symposium is being held at the Oncology Nursing Society’s 44th Annual Congress.
Thursday, April 11, 2019
Program and Lunch
777 W Convention Way
Anaheim, CA 92802
Room: Hilton Pacific C&D
Space is limited, so we suggest that you register as soon as possible!
Statement of Educational Need:
Care of patients with multiple myeloma has changed dramatically in recent years; the introduction of novel agents and improved patient care has more than doubled patient life expectancy. Research on combinations of these drugs and regimens has continued at a rapid pace, making the number of treatment options truly staggering. Nurses are responsible for educating patients and managing side effects, which enables patients to stay on therapy, and the increasing number of combination regimens greatly increases the complexity they must navigate. Given these changes in multiple myeloma (MM) treatment and practice patterns, it is more essential than ever to strengthen nurses’ knowledge of symptom management for myeloma regimens, shared decision making, and the latest diagnostic testing.
Learning Goal and Objectives:
The overarching learning objective for the program is to educate and provide practical recommendations to nurses for optimal management and care of myeloma patients. The program’s specific learning objectives are as follows:
- Identify common treatment regimens in newly diagnosed and relapsed multiple myeloma
- Discuss nursing management of MM patients receiving myeloma therapeutic regimens, including effective symptom management
- Identify the steps in shared decision making and strategies to support the patient’s input in therapeutic decisions
- Discuss the importance of survivorship care plans and practical tools for long-term management and care of MM patients
After an introduction to the multiple myeloma disease state and shared decision making, the faculty will present brief HIPAA-compliant cases of multiple myeloma patients reflecting the faculty experience. The cases are intended to provide the framework for discussing:
- Nursing perspectives for new therapeutic regimens for newly diagnosed multiple myeloma and relapsed disease
- The nurse’s role in managing symptoms, adherence, shared decision-making and advocating for patients
- Practical tools and best practice tips interwoven with the patient case stories
This activity has been designed to meet the educational needs of oncology nurses that are involved in the care of patients with multiple myeloma in either community or academic settings.
Disclosure of Conflicts of Interest:
It is the policy of the Annenberg Center for Health Sciences at Eisenhower to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, the Annenberg Center identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by the Annenberg Center to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Centers Commission on Accreditation.
A maximum of 1.5 contact hours may be earned for successful completion of this activity.
The Annenberg Center for Health Sciences at Eisenhower, the designated educational division within Eisenhower Health (EH), is nationally and regionally accredited through 9 separate accrediting bodies, including continuously since 1982 by the Accreditation Council for Continuing Medical Education (ACCME). In July 2016, the ACCME awarded the Annenberg Center Accreditation with Commendation, which confers a 6-year term of accreditation. The Annenberg Center is also accredited to award continuing nursing education (CNE) by the American Nurses Credentialing Center (ANCC).
There is no fee for this educational activity.
Meeting space has been assigned to provide a Symposium supported by International Myeloma Foundation during the Oncology Nursing Society’s (ONS) 44th Annual Congress, April 11-14, 2019 in Anaheim, CA. The Oncology Nursing Society’s assignment of meeting space does not imply product endorsement.
In accordance with accreditation requirements, this program will be certified through the joint providership of the Annenberg Center and IMF for ANCC contact hours.
This activity is supported by educational grants provided by Takeda Oncology, Celgene Corporation, Karyopharm Therapeutics Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.